Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID19- Infection With SARS-CoV-2 Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04346017
What this trial is testing

Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome

Who this might be right for
COVID-19
Francis Corazza 63
Testing effectiveness (Phase 2)Ended earlyNCT04547140
What this trial is testing

Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)

Who this might be right for
COVID-19
Grifols Therapeutics LLC 57
Not applicableWithdrawnNCT05543590
What this trial is testing

Effect of Plasmapheresis on Clinical Improvement and Biological Parameters of Patients With Long-haul COVID

Who this might be right for
Long-Haul COVID-19
Hôpital Européen Marseille
Testing effectiveness (Phase 2)Ended earlyNCT05659459
What this trial is testing

The KIN-FAST Trial (KIN001 For Accelerated Symptoms Termination) in Non Hospitalized Patients Infected With SARS-CoV-2

Who this might be right for
COVID-19
Kinarus AG 17
Testing effectiveness (Phase 2)Study completedNCT05043259
What this trial is testing

Heterologous Prime-boost Immunization with an Aerosolised Adenovirus Type-5 Vector-based COVID-19 Vaccine (Ad5-nCoV) After Priming with an Inactivated SARS-CoV-2 Vaccine

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 423
Testing effectiveness (Phase 2)Ended earlyNCT04858425
What this trial is testing

Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection

Who this might be right for
Covid19
Entero Therapeutics 166
Testing effectiveness (Phase 2)Ended earlyNCT04456413
What this trial is testing

Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection

Who this might be right for
COVID-19
Hackensack Meridian Health 21
Early research (Phase 1)UnknownNCT04747574
What this trial is testing

Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection

Who this might be right for
SARS-CoV-2
Tel-Aviv Sourasky Medical Center 35
Large-scale testing (Phase 3)Ended earlyNCT04695704
What this trial is testing

Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:

Who this might be right for
Covid19SARS (Disease)
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 86
Large-scale testing (Phase 3)Study completedNCT04494984
What this trial is testing

Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.

Who this might be right for
COVID-19
Inmunova S.A. 243
Testing effectiveness (Phase 2)UnknownNCT04931238
What this trial is testing

Efficacy and Safety of JS016 in Patients With SARS-CoV-2 Infection (COVID-19)

Who this might be right for
COVID-19SARS-CoV-2
Peking Union Medical College Hospital 200
Not applicableTemporarily pausedNCT05693064
What this trial is testing

The Impact of Chiropractic on Long COVID-19

Who this might be right for
Long COVID
Life University 40
Not applicableLooking for participantsNCT04582903
What this trial is testing

Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence

Who this might be right for
COVID-19 Infection
National Institute of Allergy and Infectious Diseases (NIAID) 5,000
Large-scale testing (Phase 3)Study completedNCT04467840
What this trial is testing

Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia

Who this might be right for
COVID-19Lung Infection
RedHill Biopharma Limited 475
Not applicableStudy completedNCT04895462
What this trial is testing

Acute Revascularization Treatment in Ischemic Stroke Patients With COVID-19

Who this might be right for
Ischemic StrokeCovid19
Centre Hospitalier Universitaire Vaudois 15,128
Large-scale testing (Phase 3)Active Not RecruitingNCT05852873
What this trial is testing

PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway

Who this might be right for
Post COVID-19 Condition, UnspecifiedSARS-CoV2 InfectionCOVID-19
Haukeland University Hospital 2,000
Testing effectiveness (Phase 2)Ended earlyNCT04322396
What this trial is testing

Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19

Who this might be right for
Virus DiseasesInfection ViralCorona Virus Infection
Chronic Obstructive Pulmonary Disease Trial Network, Denmark 117
Large-scale testing (Phase 3)Study completedNCT05783206
What this trial is testing

Evaluation of Safety & Efficacy of MIR 19 ® Inhalation Solution in Patients With Mild COVID-19

Who this might be right for
COVID-19
National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia 984
Not applicableUnknownNCT06348212
What this trial is testing

Effect of Probiotic Strain Lactobacillus Paracasei PS23 on Brain Fog in People With Long COVID

Who this might be right for
Long COVIDBrain FogCognitive Change
Taipei Veterans General Hospital, Taiwan 60
Not applicableUnknownNCT06127498
What this trial is testing

The Safety and Tolerability of A8G6 COVID-19 Neutralization Antibody Combined With Nasal Spray

Who this might be right for
SARS-CoV-2Prevention
The Second Affiliated Hospital of Chongqing Medical University 108
Next Page